Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Sep;63(9):3367–3372. doi: 10.1128/iai.63.9.3367-3372.1995

Replacement of the DR alpha chain with the E alpha chain enhances presentation of Mycoplasma arthritidis superantigen by the human class II DR molecule.

T Sawada 1, R Pergolizzi 1, K Ito 1, J Silver 1, C Atkin 1, B C Cole 1, M D Chang 1
PMCID: PMC173463  PMID: 7642264

Abstract

Mycoplasma arthritidis mitogen (MAM) is produced by an organism which can cause chronic proliferative arthritis in rodents. MAM possesses a typical superantigenic activity; it has the ability to activate a large panel of T cells which express specific V beta segments of the T-cell receptor. The presentation of MAM to T cells by antigen-presenting cells is mediated primarily through its binding to the major histocompatibility complex (MHC) class II E alpha chain in mice and the DR alpha chain in humans. However, MAM is much less active for human peripheral blood lymphocytes than for mouse splenocytes. It was suggested that a difference in MAM binding affinity between human and mouse class II molecules may account for their different MAM activities. To examine this possibility, we generated a panel of B-cell transfectants whose DR molecule is composed of either the DR alpha or the E alpha chain paired with a DR3 beta chain. The ability of these transfectants to present MAM to human peripheral T cells was analyzed. Our data show that transfectants expressing E alpha DR beta chimeric molecules have higher MAM-presenting activity than transfectants expressing wild-type DR alpha DR beta molecules, while the latter have higher activity in stimulating DR3-alloreactive T cells. Since both types of transfectants present MAM to T cells expressing the same T-cell receptor V beta gene families, the higher MAM-presenting activity of the E alpha transfectant is not due to its ability to interact with a different set of T cells. Furthermore, both the E alpha 1 and E alpha 2 domains contribute to this increased affinity for MAM binding. Taken together, our data suggest that there may be multiple MAM binding sites on the E alpha and DR alpha chains and residues unique to the E alpha chain may provide additional affinity for MAM.

Full Text

The Full Text of this article is available as a PDF (233.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akolkar P. N., Gulwani-Akolkar B., Pergolizzi R., Bigler R. D., Silver J. Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J Immunol. 1993 Apr 1;150(7):2761–2773. [PubMed] [Google Scholar]
  2. Atkin C. L., Cole B. C., Sullivan G. J., Washburn L. R., Wiley B. B. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. V. A small basic protein from culture supernatants is a potent T cell mitogen. J Immunol. 1986 Sep 1;137(5):1581–1589. [PubMed] [Google Scholar]
  3. Atkin C. L., Wei S., Cole B. C. The Mycoplasma arthritidis superantigen MAM: purification and identification of an active peptide. Infect Immun. 1994 Dec;62(12):5367–5375. doi: 10.1128/iai.62.12.5367-5375.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baccala R., Smith L. R., Vestberg M., Peterson P. A., Cole B. C., Theofilopoulos A. N. Mycoplasma arthritidis mitogen. V beta engaged in mice, rats, and humans, and requirement of HLA-DR alpha for presentation. Arthritis Rheum. 1992 Apr;35(4):434–442. doi: 10.1002/art.1780350413. [DOI] [PubMed] [Google Scholar]
  5. Bhardwaj N., Hodtsev A. S., Nisanian A., Kabak S., Friedman S. M., Cole B. C., Posnett D. N. Human T-cell responses to Mycoplasma arthritidis-derived superantigen. Infect Immun. 1994 Jan;62(1):135–144. doi: 10.1128/iai.62.1.135-144.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown J. H., Jardetzky T. S., Gorga J. C., Stern L. J., Urban R. G., Strominger J. L., Wiley D. C. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993 Jul 1;364(6432):33–39. doi: 10.1038/364033a0. [DOI] [PubMed] [Google Scholar]
  7. Buus S., Sette A., Colon S. M., Miles C., Grey H. M. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science. 1987 Mar 13;235(4794):1353–1358. doi: 10.1126/science.2435001. [DOI] [PubMed] [Google Scholar]
  8. Choi Y. W., Kotzin B., Herron L., Callahan J., Marrack P., Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8941–8945. doi: 10.1073/pnas.86.22.8941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cole B. C., Atkin C. L. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol Today. 1991 Aug;12(8):271–276. doi: 10.1016/0167-5699(91)90125-D. [DOI] [PubMed] [Google Scholar]
  10. Cole B. C., Balderas R. A., Ahmed E. A., Kono D., Theofilopoulos A. N. Genomic composition and allelic polymorphisms influence V beta usage by the Mycoplasma arthritidis superantigen. J Immunol. 1993 Apr 15;150(8 Pt 1):3291–3299. [PubMed] [Google Scholar]
  11. Cole B. C., David C. S., Lynch D. H., Kartchner D. R. The use of transfected fibroblasts and transgenic mice establishes that stimulation of T cells by the Mycoplasma arthritidis mitogen is mediated by E alpha. J Immunol. 1990 Jan 15;144(2):420–424. [PubMed] [Google Scholar]
  12. Cole B. C., Griffiths M. M. Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM. Arthritis Rheum. 1993 Jul;36(7):994–1002. doi: 10.1002/art.1780360717. [DOI] [PubMed] [Google Scholar]
  13. Cole B. C., Kartchner D. R., Wells D. J. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis (MAM). VIII. Selective activation of T cells expressing distinct V beta T cell receptors from various strains of mice by the "superantigen" MAM. J Immunol. 1990 Jan 15;144(2):425–431. [PubMed] [Google Scholar]
  14. Cole B. C., Wells D. J. Immunosuppressive properties of the Mycoplasma arthritidis T-cell mitogen in vivo: inhibition of proliferative responses to T-cell mitogens. Infect Immun. 1990 Jan;58(1):228–236. doi: 10.1128/iai.58.1.228-236.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fleischer B., Gerardy-Schahn R., Metzroth B., Carrel S., Gerlach D., Köhler W. An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction. J Immunol. 1991 Jan 1;146(1):11–17. [PubMed] [Google Scholar]
  16. Friedman S. M., Crow M. K., Tumang J. R., Tumang M., Xu Y. Q., Hodtsev A. S., Cole B. C., Posnett D. N. Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against V beta 17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cells. J Exp Med. 1991 Oct 1;174(4):891–900. doi: 10.1084/jem.174.4.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Friedman S. M., Posnett D. N., Tumang J. R., Cole B. C., Crow M. K. A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. Arthritis Rheum. 1991 Apr;34(4):468–480. doi: 10.1002/art.1780340412. [DOI] [PubMed] [Google Scholar]
  18. Fu X. T., Karr R. W. HLA-DR alpha chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes. Hum Immunol. 1994 Apr;39(4):253–260. doi: 10.1016/0198-8859(94)90268-2. [DOI] [PubMed] [Google Scholar]
  19. Hingorani R., Choi I. H., Akolkar P., Gulwani-Akolkar B., Pergolizzi R., Silver J., Gregersen P. K. Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects. J Immunol. 1993 Nov 15;151(10):5762–5769. [PubMed] [Google Scholar]
  20. Johnson A. H., Tang T. F., Cowell V., Hurley C. K. The impact of naturally occurring DR3 microvariants, DRw17 and DRw18, on T-cell allorecognition. Hum Immunol. 1991 Sep;32(1):46–55. doi: 10.1016/0198-8859(91)90116-q. [DOI] [PubMed] [Google Scholar]
  21. Kotzin B. L., Leung D. Y., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv Immunol. 1993;54:99–166. doi: 10.1016/s0065-2776(08)60534-9. [DOI] [PubMed] [Google Scholar]
  22. Lawrance S. K., Karlsson L., Price J., Quaranta V., Ron Y., Sprent J., Peterson P. A. Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha 0 mutant mice. Cell. 1989 Aug 11;58(3):583–594. doi: 10.1016/0092-8674(89)90439-x. [DOI] [PubMed] [Google Scholar]
  23. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 May 11;248(4956):705–711. doi: 10.1126/science.2185544. [DOI] [PubMed] [Google Scholar]
  24. Mellins E., Cameron P., Amaya M., Goodman S., Pious D., Smith L., Arp B. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides. J Exp Med. 1994 Feb 1;179(2):541–549. doi: 10.1084/jem.179.2.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mellins E., Woelfel M., Pious D. Importance of HLA-DQ and -DP restriction elements in T-cell responses to soluble antigens: mutational analysis. Hum Immunol. 1987 Mar;18(3):211–223. doi: 10.1016/0198-8859(87)90086-3. [DOI] [PubMed] [Google Scholar]
  26. Mengle-Gaw L., McDevitt H. O. Genetics and expression of mouse Ia antigens. Annu Rev Immunol. 1985;3:367–396. doi: 10.1146/annurev.iy.03.040185.002055. [DOI] [PubMed] [Google Scholar]
  27. Scholl P. R., Sekaly R. P., Diez A., Glimcher L. H., Geha R. S. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules. Eur J Immunol. 1990 Sep;20(9):1911–1916. doi: 10.1002/eji.1830200907. [DOI] [PubMed] [Google Scholar]
  28. Wilson R. K., Lai E., Concannon P., Barth R. K., Hood L. E. Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families. Immunol Rev. 1988 Jan;101:149–172. doi: 10.1111/j.1600-065x.1988.tb00736.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES